Sakir Mutevelic, MD, MSc, Chief Medical Officer at Curium said: “We are proud to announce the completion of enrollment in the ECLIPSE trial, and would like to thank the patients, trial investigators, clinical research partners, and our Curium cross-functional teams for their dedication and commitment. We are looking forward to delivering the study results once the data matures.”